Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C181801> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- NCIT_C181801 IAO_0000115 "A chemoimmunotherapy regimen consisting of paclitaxel and pembrolizumab that can be used for the treatment of recurrent and metastatic hormone receptor-negative, HER-2 (EGFR2; ErbB2)-negative and PD-L1-positive breast cancer." @default.
- NCIT_C181801 NCIT_NHC0 "C181801" @default.
- NCIT_C181801 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C181801 NCIT_P108 "Paclitaxel/Pembrolizumab Regimen" @default.
- NCIT_C181801 NCIT_P208 "CL1664720" @default.
- NCIT_C181801 NCIT_R123 NCIT_C106432 @default.
- NCIT_C181801 NCIT_R123 NCIT_C124946 @default.
- NCIT_C181801 NCIT_R123 NCIT_C128037 @default.
- NCIT_C181801 NCIT_R123 NCIT_C1411 @default.
- NCIT_C181801 NCIT_R123 NCIT_C141144 @default.
- NCIT_C181801 NCIT_R123 NCIT_C143250 @default.
- NCIT_C181801 NCIT_R123 NCIT_C1490 @default.
- NCIT_C181801 NCIT_R123 NCIT_C163758 @default.
- NCIT_C181801 NCIT_R123 NCIT_C186664 @default.
- NCIT_C181801 NCIT_R123 NCIT_C1908 @default.
- NCIT_C181801 NCIT_R123 NCIT_C1909 @default.
- NCIT_C181801 NCIT_R123 NCIT_C1913 @default.
- NCIT_C181801 NCIT_R123 NCIT_C20401 @default.
- NCIT_C181801 NCIT_R123 NCIT_C25974 @default.
- NCIT_C181801 NCIT_R123 NCIT_C273 @default.
- NCIT_C181801 NCIT_R123 NCIT_C274 @default.
- NCIT_C181801 NCIT_R123 NCIT_C307 @default.
- NCIT_C181801 NCIT_R123 NCIT_C308 @default.
- NCIT_C181801 NCIT_R123 NCIT_C552 @default.
- NCIT_C181801 NCIT_R123 NCIT_C616 @default.
- NCIT_C181801 NCIT_R123 NCIT_C67437 @default.
- NCIT_C181801 NCIT_R123 NCIT_C718 @default.
- NCIT_C181801 NCIT_R123 NCIT_C860 @default.
- NCIT_C181801 normalizedInformationContent "100" @default.
- NCIT_C181801 referenceCount "1" @default.
- NCIT_C181801 hasExactSynonym "Paclitaxel-Pembrolizumab Regimen" @default.
- NCIT_C181801 hasExactSynonym "Paclitaxel-Pembrolizumab" @default.
- NCIT_C181801 hasExactSynonym "Paclitaxel/Pembrolizumab Regimen" @default.
- NCIT_C181801 hasExactSynonym "Paclitaxel/Pembrolizumab" @default.
- NCIT_C181801 hasExactSynonym "Pembrolizumab Plus Paclitaxel" @default.
- NCIT_C181801 hasExactSynonym "Pembrolizumab-Paclitaxel" @default.
- NCIT_C181801 hasExactSynonym "Pembrolizumab/Paclitaxel Regimen" @default.
- NCIT_C181801 hasExactSynonym "Pembrolizumab/Paclitaxel" @default.
- NCIT_C181801 hasExactSynonym "Taxol/Keytruda" @default.
- NCIT_C181801 inSubset NCIT_C160950 @default.
- NCIT_C181801 inSubset NCIT_C160952 @default.
- NCIT_C181801 type Class @default.
- NCIT_C181801 isDefinedBy ncit.owl @default.
- NCIT_C181801 label "Paclitaxel/Pembrolizumab Regimen" @default.
- NCIT_C181801 subClassOf B34c1a5f8860121c53c488045032b2369 @default.
- NCIT_C181801 subClassOf B7bf04cf0324826a58b1fa98430aae15f @default.
- NCIT_C181801 subClassOf Bc120e120ec9e6f439b74431caa495c6a @default.
- NCIT_C181801 subClassOf Bc1cf69f97a9ad618a4e9b718a4efc4de @default.
- NCIT_C181801 subClassOf NCIT_C12218 @default.
- NCIT_C181801 subClassOf NCIT_C181801 @default.
- NCIT_C181801 subClassOf NCIT_C62634 @default.
- NCIT_C181801 subClassOf NCIT_C63358 @default.